NuView Life Sciences

About:

NuView Life Sciences is a medical imaging and diagnostic company committed to addressing urgent and unmet medical needs.

Website: https://nuviewlifesciences.com/

Top Investors: The Global Emerging Markets Group

Description:

NuView Life Sciences is a biotechnology company based in Park City, Utah focused on precision cancer diagnostics and therapeutics improving patient outcomes and reducing healthcare costs. NuView Life Sciences has a strong mission – to change the way many types of cancer are diagnosed and treated using precision medicine technology. Diagnosing and treating cancer with a targeted, specific approach to the disease will help to increase positive patient outcomes while also driving down costs incurred by patients, healthcare providers, and third-party insurance payers. NuView Life Sciences is an inventive, cutting-edge biotechnology company working to change the way cancer is currently diagnosed and treated. This positioning is dependent on attention to NuView Life Sciences’s platform technology, NV-VPAC1TM , and its action in the body.

Total Funding Amount:

$90M

Headquarters Location:

Park City, Utah, United States

Founded Date:

2005-01-01

Contact Email:

admin(AT)nuviewlifesciences.com

Founders:

Paul Crowe

Number of Employees:

1-10

Last Funding Date:

2020-08-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai